Invitrogen Receives Approval from Health Canada for System to Help Determine Organ Transplant Compatibility (Centre Daily Times) PDF Print

Invitrogen, a division of Life Technologies Corporation (NASDAQ:LIFE), today announced that its DynaChip ® HLA Antibody Analysis System has received approval from Health Canada’s Medical Device Bureau for the detection and identification of antibodies to human leukocyte antigen (HLA) markers, which is an essential step in determining the compatibility of organ donors.

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.